Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Bill would broaden evidence considered for rare and life‑threatening conditions in state health‑tech reviews
Summary
SB 59 15 would direct the Health Technology Assessment Program to prioritize technologies recommended in Medicare or national guidelines and require broader evidence review (including non‑randomized trials) for life‑threatening or rare conditions so some treatments are not excluded from coverage.
Committee staff opened Feb. 18 with a briefing on Senate Bill 59 15, which revises the Health Technology Assessment Program to add a prioritization category for technologies recommended for Medicare populations or in national treatment guidelines and to require the clinical committee to consider all clinical trials…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
